CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThis chapter by choosing the field of neglected tropical diseases (NTDs) as the background therapeutic area describes efforts to develop multitarget drugs for solving the vexing medical problem. Among the various NTDs, the chapter focuses on three diseases most significant in terms of morbidity and mortality: human African trypanosomiasis (HAT), Chagas' disease, and leishmaniasis. A numerous class of hybrid anti‐trypanosomatid molecules is represented by the so‐called targeted drugs, which combine a framework with antiparasitic activity with a fragment recognized by a parasite transporter. A multitarget‐directed ligand (MTDL) is a single chemical entity that simultaneously recognizes different targets inside the parasite. The chapter then presents the report on the different approaches that are exploited to obtain innovative hybrid small molecules. Modern drug discovery for NTDs is carried out using both target‐based and phenotypic approaches. The target‐based approaches to NTDs are a widely used route for drug discovery programs aimed at identifying new lead compounds for diseases.
| Titolo: | Drug Discovery Strategies for the Generation of Multitarget Ligands against Neglected Tropical Diseases | |
| Autore/i: | Gandini, Annachiara; Prati, Federica; Uliassi, Elisa; Bolognesi, Maria L. | |
| Autore/i Unibo: | ||
| Anno: | 2017 | |
| Serie: | ||
| Titolo del libro: | Drug Selectivity: An Evolving Concept in Medicinal Chemistry | |
| Pagina iniziale: | 135 | |
| Pagina finale: | 159 | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1002/9783527674381.ch6 | |
| Abstract: | This chapter by choosing the field of neglected tropical diseases (NTDs) as the background therapeutic area describes efforts to develop multitarget drugs for solving the vexing medical problem. Among the various NTDs, the chapter focuses on three diseases most significant in terms of morbidity and mortality: human African trypanosomiasis (HAT), Chagas' disease, and leishmaniasis. A numerous class of hybrid anti‐trypanosomatid molecules is represented by the so‐called targeted drugs, which combine a framework with antiparasitic activity with a fragment recognized by a parasite transporter. A multitarget‐directed ligand (MTDL) is a single chemical entity that simultaneously recognizes different targets inside the parasite. The chapter then presents the report on the different approaches that are exploited to obtain innovative hybrid small molecules. Modern drug discovery for NTDs is carried out using both target‐based and phenotypic approaches. The target‐based approaches to NTDs are a widely used route for drug discovery programs aimed at identifying new lead compounds for diseases. | |
| Data stato definitivo: | 17-feb-2019 | |
| Appare nelle tipologie: |
File in questo prodotto:
Copyright © 2022